Holen Sie sich die Stockscreener-App
36.01
0.45%
0.16
Schlusskurs vom Vortag:
$35.85
Offen:
$36.4
24-Stunden-Volumen:
476.25K
Relative Volume:
0.72
Marktkapitalisierung:
$2.07B
Einnahmen:
$772.53M
Nettoeinkommen (Verlust:
$180.90M
KGV:
11.61
EPS:
3.1024
Netto-Cashflow:
$258.73M
1W Leistung:
-3.38%
1M Leistung:
+0.70%
6M Leistung:
-1.80%
1J Leistung:
-7.84%
1-Tages-Spanne:
$35.97
$36.95
1-Wochen-Bereich:
$35.57
$38.21
52-Wochen-Spanne:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Firmenname
Harmony Biosciences Holdings Inc
Sektor
Branche
Telefon
(484) 539-9800
Adresse
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
36.01 | 2.06B | 772.53M | 180.90M | 258.73M | 3.1024 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-11 | Fortgesetzt | UBS | Neutral |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-09-10 | Eingeleitet | UBS | Buy |
| 2024-06-21 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Herabstufung | Goldman | Neutral → Sell |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-14 | Hochstufung | Janney | Neutral → Buy |
| 2022-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-13 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-04 | Eingeleitet | Raymond James | Outperform |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-03-29 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-14 | Eingeleitet | Goldman | Neutral |
| 2020-09-14 | Eingeleitet | Jefferies | Buy |
| 2020-09-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
LSV Asset Management Increases Stake in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Understanding Momentum Shifts in (HRMY) - Stock Traders Daily
Trend Review: Is Harmony Biosciences Holdings Inc part of any ETFWeekly Stock Report & Community Consensus Trade Alerts - baoquankhu1.vn
MACD Signal: Is Harmony Biosciences Holdings Inc impacted by rising ratesJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn
Can Harmony Biosciences Holdings Inc. stock attract ESG capital inflowsJuly 2025 Earnings & Weekly High Potential Alerts - mfd.ru
Wall Street Analysts Believe Harmony Biosciences (HRMY) Could Rally 26.95%: Here's is How to Trade - Finviz
Assessing Harmony Biosciences (HRMY) Valuation As Analyst Optimism And Earnings Anticipation Grow - Yahoo Finance
Where Harmony Biosciences Hldgs Stands With Analysts - Benzinga
HRMY vs. ARGX: Which Stock Is the Better Value Option? - Yahoo Finance UK
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? - Yahoo Finance
HRMY Sees Analyst Downgrade and Price Target Increase by UBS | H - GuruFocus
Harmony Biosciences (NASDAQ:HRMY) Receives "Neutral" Rating from UBS Group - MarketBeat
Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook Reveals a 25% Upside Potential in a Rising Biotech Star - DirectorsTalk Interviews
A Look At Harmony Biosciences (HRMY) Valuation After Recent Share Price Momentum - Sahm
Harmony Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - Business Wire
New York State Common Retirement Fund Acquires 29,501 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Zacks.com featured highlights include Harmony Biosciences, Adecoagro, Sociedad Quimica y Minera de Chile, Angi and PHINIA - The Globe and Mail
Movement Recap: Is AT T Inc forming a double bottom2025 Market Trends & Fast Gain Swing Alerts - baoquankhu1.vn
5 Value Picks Amid AI-Driven Tech Sell-Off & U.S.-Iran Tensions - TradingView
Avoiding Lag: Real-Time Signals in (HRMY) Movement - Stock Traders Daily
Harmony Biosciences Makes The Grade (NASDAQ:HRMY) - Seeking Alpha
Zacks.com featured highlights include Harmony Biosciences, Universal Health Services, Concentrix and Global Payments - Nasdaq
CFO’s Full Share Exit Contrasts With Harmony’s Positive WAKIX Growth Story - Yahoo! Finance Canada
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2025 Earnings Call Transcript - MSN
Is Harmony Biosciences (HRMY) Pricing Reflect Its Cash Flow Potential After Recent Share Weakness - Sahm
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update - MarketBeat
Harmony Biosciences Chief Financial Officer Sells Shares Again After Previous Exit From Company Equity - AOL.com
Capital Management Corp VA Sells 29,654 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Harmony Biosciences CFO Fully Exits Equity Ownership - Intellectia AI
Harmony Biosciences' CFO Sells All of His Insider Shares, Worth $752,800 - Yahoo Finance
Harmony Biosciences' CFO Sells All of Her Insider Shares, Worth $752,800 - The Motley Fool
Is Harmony Biosciences (HRMY) a Solid Growth Stock? 3 Reasons to Think "Yes" - sharewise.com
Hussman Strategic Advisors Inc. Reduces Stock Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Insider Sell: Sandip Kapadia Sells Shares of Harmony Biosciences Holdings Inc (HRMY) - GuruFocus
Sandip Kapadia Sells 3,746 Shares of Harmony Biosciences (NASDAQ:HRMY) Stock - MarketBeat
How Harmony Biosciences Can Prove Its Skeptics Wrong - Finviz
What’s the analyst consensus on Harmony Biosciences Holdings Inc.Earnings Beat & AI Powered Market Entry Ideas - mfd.ru
Harmony Biosciences: Still Undervalued But Unappealing Risk/Reward (Downgrade) - Seeking Alpha
Is Harmony Biosciences (HRMY) Attractive After Recent Price Weakness And DCF Upside Potential? - Yahoo Finance
Evaluating Harmony Biosciences (HRMY) Valuation After Stronger Fundamentals And Breakout Signals - Yahoo Finance
Harmony Biosciences Holdings (HRMY) Investor Outlook: A Promising 24.34% Upside Potential - DirectorsTalk Interviews
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? - Finviz
Harmony Biosciences Holdings, Inc. $HRMY Shares Bought by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Did Stronger Fundamentals and Bullish Technicals Just Shift Harmony Biosciences Holdings' (HRMY) Investment Narrative? - Yahoo Finance
How A New Price Target Is Reshaping The Story For Harmony Biosciences Holdings (HRMY) - Yahoo Finance
Assessing Harmony Biosciences (HRMY) Valuation As Growth, Financial Strength And Technical Signals Attract Investors - Sahm
I Was Shocked to Find This Value-Priced Biotech Growth Stock - Finviz
HRMY or ARGX: Which Is the Better Value Stock Right Now? - Yahoo Finance
Should Value Investors Buy Harmony Biosciences (HRMY) Stock? - Yahoo Finance
Top 5 US Stocks To Buy In February 2026 - Investing.com
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):